Table 1.

Summary of literature on cell and biomaterial combinations used for tissue engineered skeletal muscle.

Red lettering indicates functional studies were performed on TE constructs implanted in vivo (i.e., contraction of engineered/retrieved constructs were evaluated. Highlighted in yellow are the engineered skeletal muscle tissues that were implanted, as well as the site and nature of implantation. Abbreviations: EH network: polymeric scaffolds (EH network) made from the cyclic acetal monomer, 5-ethyl-5-(hydroxymethyl)-β, β-dimethyl- 1,3-dioxane-2-ethanol diacrylate (EHD); PEG, polyethylene glycol; Poly-hydroxyethyl methacrylate (pHEMA)-gelatin cryogel scaffold; MPEG–PCL, methoxy poly(ethylene glycol) poly(3-caprolactone); PDMS, polydimethylsiloxane; PGA, poly glycolic acid; PLGA, poly-lactic-glycolic acid; PLC, L-lactide/epsilon-caprolactone copolymer; PLA, poly lactic acid; PLLA, poly (L-lactic acid); PLL, poly (L-Lysine); PMM, Poly (methyl methacrylate); PANi, polyaniline; PEDOT:PSS, poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate); TA, tibialis anterior muscle; LD, latissimus dorsi muscle; SCI, subcutaneous implantation; MPCs, muscle progenitor/precursor cells; ADSCs, adipose-derived stem cells; MSCs, mesenchymal stem cells; ECs, endothelial cells.